Cargando…
Anti-CD20 therapy depletes activated myelin-specific CD8(+) T cells in multiple sclerosis
CD8(+) T cells are believed to play an important role in multiple sclerosis (MS), yet their role in MS pathogenesis remains poorly defined. Although myelin proteins are considered potential autoantigenic targets, prior studies of myelin-reactive CD8(+) T cells in MS have relied on in vitro stimulati...
Autores principales: | Sabatino, Joseph J., Wilson, Michael R., Calabresi, Peter A., Hauser, Stephen L., Schneck, Jonathan P., Zamvil, Scott S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6926057/ https://www.ncbi.nlm.nih.gov/pubmed/31748274 http://dx.doi.org/10.1073/pnas.1915309116 |
Ejemplares similares
-
Can Systemic Anti-CD20 B Cell-Depleting Antibodies Eliminate Meningeal Follicles in Multiple Sclerosis?
por: Gupta, Sasha, et al.
Publicado: (2021) -
B cells reappear less mature and more activated after their anti-CD20–mediated depletion in multiple sclerosis
por: Nissimov, Nitzan, et al.
Publicado: (2020) -
Ocrelizumab Depletes CD20(+) T Cells in Multiple Sclerosis Patients
por: Gingele, Stefan, et al.
Publicado: (2018) -
Unique invariant CD8(+) T cell population persists in MS
por: Sabatino, Joseph J., et al.
Publicado: (2015) -
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity
por: Shinoda, Koji, et al.
Publicado: (2023)